Toronto - Delayed Quote • CAD
Oncolytics Biotech Inc. (ONC.TO)
At close: 3:59 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
33,791.0000
33,791.0000
26,924.0000
26,235.0000
25,459.0000
Operating Income
-33,791.0000
-33,791.0000
-26,924.0000
-26,235.0000
-25,459.0000
Net Non Operating Interest Income Expense
1,326.0000
1,326.0000
528.0000
99.0000
121.0000
Other Income Expense
4,810.0000
4,810.0000
1,645.0000
-119.0000
2,833.0000
Pretax Income
-27,655.0000
-27,655.0000
-24,751.0000
-26,255.0000
-22,505.0000
Tax Provision
97.0000
97.0000
84.0000
49.0000
--
Net Income Common Stockholders
-27,752.0000
-27,752.0000
-24,835.0000
-26,304.0000
-22,505.0000
Diluted NI Available to Com Stockholders
-27,752.0000
-27,752.0000
-24,835.0000
-26,304.0000
-22,505.0000
Basic EPS
-0.41
--
-0.43
-0.49
-0.56
Diluted EPS
-0.41
--
-0.43
-0.49
-0.56
Basic Average Shares
67,624.0360
--
58,029.7450
53,513.2250
40,338.7890
Diluted Average Shares
67,624.0360
--
58,029.7450
53,513.2250
40,338.7890
Total Operating Income as Reported
--
--
--
-26,234.9450
-25,459.0060
Total Expenses
33,791.0000
33,791.0000
26,924.0000
26,235.0000
25,459.0000
Net Income from Continuing & Discontinued Operation
-27,752.0000
-27,752.0000
-24,835.0000
-26,304.0000
-22,505.0000
Normalized Income
-30,638.0000
-30,638.0000
-26,048.8455
-26,216.5350
-25,338.0000
Interest Income
1,326.0000
1,326.0000
528.0000
99.0000
121.0000
Net Interest Income
1,326.0000
1,326.0000
528.0000
99.0000
121.0000
EBIT
-33,791.0000
-33,791.0000
-26,924.0000
-26,235.0000
-25,459.0000
EBITDA
-33,388.0000
-33,388.0000
-26,532.0000
-25,783.0000
-25,013.0000
Reconciled Depreciation
403.0000
403.0000
392.0000
452.0000
446.0000
Net Income from Continuing Operation Net Minority Interest
-27,752.0000
-27,752.0000
-24,835.0000
-26,304.0000
-22,505.0000
Total Unusual Items Excluding Goodwill
4,810.0000
4,810.0000
1,645.0000
-119.0000
2,833.0000
Total Unusual Items
4,810.0000
4,810.0000
1,645.0000
-119.0000
2,833.0000
Normalized EBITDA
-38,198.0000
-38,198.0000
-28,177.0000
-25,664.0000
-27,846.0000
Tax Rate for Calcs
0.0004
0.0004
0.0003
0.0003
--
Tax Effect of Unusual Items
1,924.0000
1,924.0000
431.1545
-31.5350
--
12/31/2020 - 6/1/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TH.TO Theratechnologies Inc.
1.8000
0.00%
MDNA.TO Medicenna Therapeutics Corp.
2.4900
+27.69%
AEZS.TO Aeterna Zentaris Inc.
2.6500
-0.38%
MBX.TO Microbix Biosystems Inc.
0.3250
-2.99%
APS.TO Aptose Biosciences Inc.
1.7000
+4.94%
ATE.TO Antibe Therapeutics Inc.
0.2950
0.00%
BCT.TO BriaCell Therapeutics Corp.
2.9300
-2.66%
SVA.TO Sernova Corp.
0.4400
+3.53%
HBP.TO Helix BioPharma Corp.
0.2100
0.00%
MDMA.CN Pharmala Biotech Holdings Inc.
0.2200
0.00%